Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · IEX Real-Time Price · USD
2.770
+0.040 (1.47%)
May 17, 2024, 4:30 PM EDT - Market closed

Lisata Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Revenue
0000000022.4917.94
Upgrade
Revenue Growth (YoY)
--------25.36%22.30%
Upgrade
Cost of Revenue
0000000020.1615.68
Upgrade
Gross Profit
000000002.332.26
Upgrade
Selling, General & Admin
12.9714.1411.479.899.39.3911.7512.830.0130.81
Upgrade
Research & Development
12.7313.0717.589.2510.87.5915.8416.723.929.19
Upgrade
Other Operating Expenses
030.3900000062.270
Upgrade
Operating Expenses
25.7157.629.0519.1520.0916.9927.5929.5116.1860
Upgrade
Operating Income
-25.71-57.6-29.05-19.15-20.09-16.99-27.59-29.5-113.85-57.74
Upgrade
Interest Expense / Income
000000.010.381.782.130.76
Upgrade
Other Expense / Income
-2.54-0.9-0.08-0.12-0.73-0.83-39.421.37-17.85-3.52
Upgrade
Pretax Income
-23.17-56.7-28.97-19.02-19.36-16.1711.45-32.66-98.13-54.98
Upgrade
Income Tax
-2.33-2.48-1.51-10.8700-11.530-17.24-0.1
Upgrade
Net Income
-20.84-54.23-27.47-8.15-19.36-16.1722.98-32.66-80.89-54.87
Upgrade
Shares Outstanding (Basic)
8541111000
Upgrade
Shares Outstanding (Diluted)
8541111000
Upgrade
Shares Change
55.85%40.46%258.27%49.54%6.56%8.03%36.97%34.99%48.09%59.82%
Upgrade
EPS (Basic)
-2.58-10.47-7.45-7.95-28.20-25.0538.40-74.85-250.04-251.99
Upgrade
EPS (Diluted)
-2.58-10.47-7.45-7.95-28.20-25.0538.40-74.85-250.04-251.99
Upgrade
Free Cash Flow
-20.03-21.46-22.31-8.84-18.88-20.12-21.01-24.77-42.44-50.55
Upgrade
Free Cash Flow Per Share
-2.48-4.14-6.05-8.59-27.43-31.15-35.14-56.73-131.24-231.48
Upgrade
Gross Margin
--------10.36%12.60%
Upgrade
Operating Margin
---------506.28%-321.88%
Upgrade
Profit Margin
---------359.69%-305.89%
Upgrade
Free Cash Flow Margin
---------188.74%-281.81%
Upgrade
Effective Tax Rate
-------100.65%---
Upgrade
EBITDA
-22.98-56.64-28.92-18.96-19.3-15.9412.2-30.43-93.31-52.03
Upgrade
EBITDA Margin
---------414.96%-290.07%
Upgrade
Depreciation & Amortization
0.190.070.060.060.070.230.370.452.692.19
Upgrade
EBIT
-23.17-56.7-28.97-19.02-19.36-16.1611.83-30.88-96-54.22
Upgrade
EBIT Margin
---------426.91%-302.26%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).